Three Chemists Honored by American Chemical Society
The researchers recognized for outstanding scholarshipSeptember 29, 2010
Marks, Vladimir N. Ipatieff Research Professor of Chemistry in the Weinberg College of Arts and Sciences and professor of materials science and engineering in the McCormick School of Engineering and Applied Science, received the ACS Arthur C. Cope Senior Scholar Award and a $40,000 unrestricted research grant for excellence in organic chemistry. Marks also received the Santa Clara Valley (Silicon Valley) Section of the ACS Harry and Carol Mosher Award recognizing outstanding scholarship and service to ACS.
Marks is a world leader in the fields of organometallic chemistry, chemical catalysis, materials science, organic electronics, photovoltaics and nanotechnology.
Silverman, John Evans Professor of Chemistry, received the ACS E. B. Hershberg Award for Important Discoveries in Medicinally Active Substances. Much of his research has been in the area of epilepsy, cancer and neurodegenerative diseases, such as Parkinson's disease, cerebral palsy and amyotrophic lateral sclerosis.
Kung, professor of chemical and biological engineering, received the Gabor A. Somorjai Award for Creative Research in Catalysis. The award recognizes outstanding theoretical, experimental, or developmental research resulting in the advancement of understanding or application of catalysis.
The researchers have received numerous awards throughout their careers.
Among Marks’ recent honors are the Nichols Medal from the American Chemical Society, the Nelson W. Taylor Award from the Pennsylvania State University, the Herman Pines Award from the Chicago Section of the North American Catalysis Society, the Principe de Asturias Prize for Technical and Scientific Research, the Wihelm Manchot Prize from the Technical University of Munich, and the U.S. National Medal of Science.
Silverman has previously received the Perkin Medal from the Society of Chemical Industry, the ACS Arthur C. Cope Senior Scholar Award, an Alumni Fellow Award from The Pennsylvania State University, an Alfred P. Sloan Research Fellowship, a National Institutes of Health Career Development Award, the Northwestern University Alumni Association Excellence in Teaching Award, and the E. LeRoy Hall Award for Teaching Excellence. He was named to the ACS Medicinal Chemistry Hall of Fame and a fellow of American Association for the Advancement of Science.
In 1989 Silverman and his Northwestern research group first synthesized an organic molecule, which is currently marketed by Pfizer as Lyrica, a drug used to combat epilepsy, neuropathic pain and fibromyalgia. Silverman donated to the University a portion of the royalties that he receives from sales of the drug. The gift from Silverman and his wife, Barbara, helped fund the construction of the Richard and Barbara Silverman Hall for Molecular Therapeutics and Diagnostics, which opened in November of 2009.
Kung was recipient of the North American Catalysis Society P.H. Emmett Award and Robert Burwell Lectureship Award, the Herman Pines Award from the Chicago Catalysis Club, the Catalysis Society of South Africa Eminent Visitor Award, the Cross-Canada Lectureship of the Catalysis Division of the Chemical Institute of Canada, and the Ernest Thiele Award of American Institute of Chemical Engineers, Chicago Section. He is a fellow of American Association for the Advancement of Science.